Innovation: Shortening The Path To Commercialization In Advanced Therapies
Source: Precision ADVANCE
In this panel sponsored by Precision ADVANCE, Clare Sarvary Fourrier, SVP of Operational Strategy (EU) for Precision for Medicine moderates a discussion with industry experts to share perspectives on the current state of the cell and gene therapy industry and provide key insights in shortening time-to-market for advanced therapies.
- Alex Grosvenor SVP, PRECISIONadvisors | Precision Value & Health
- Dave Lennon President | Novartis Gene Therapies
- Anshul Mangal President | Project Farma (PF) & Precision ADVANCE
- Parag V. Meswani Chief Commercial Officer | Sio Gene Therapies
- Pascal Touchon President & CEO | Atara Biotherapeutics
VIEW THE WEBINAR!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.
Subscribe to Cell & Gene
X
Subscribe to Cell & Gene
Precision ADVANCE
This website uses cookies to ensure you get the best experience on our website. Learn more